Andrew C Parrott. Show Affiliations »
Abstract
Mesh: See more » Catha/adverse effectsCatha/classificationDrug-Related Side Effects and Adverse Reactions/classificationHallucinogens/adverse effectsHarm ReductionHumansN-Methyl-3,4-methylenedioxyamphetamine/adverse effectsN-Methyl-3,4-methylenedioxyamphetamine/classificationPharmaceutical Preparations/classificationRisk Assessment/classificationSubstance-Related Disorders/etiologyUnited Kingdom
Substances: See more » HallucinogensPharmaceutical PreparationsN-Methyl-3,4-methylenedioxyamphetamine
Year: 2007 PMID: 17896347 DOI: 10.1002/hup.874
Source DB: PubMed Journal: Hum Psychopharmacol ISSN: 0885-6222 Impact factor: 1.672